In NSCLC cells, 3 was demonstrated to directly inhibit T-lymphokine-activated killer cell-originated protein kinase (TOPK), a serine/threonine kinase implicated in tumour proliferation and metastasis. The gene discussed is PBK; the disease is neoplasm.